09.03.2011 • NewsJean-Paul ClozelActelionElliott Advisors

Actelion's Rob Cawthorn Fends Off Criticism Ahead Of Annual Meeting

Swiss biotech group Actelion published a white paper defending its corporate governance as it aims to counter criticism from its largest shareholder Elliott Advisers ahead of a shareholder meeting.

"We see corporate governance as the underpinning foundation for maximizing value creation for our shareholders," Rob Cawthorn, chairman of the board, said in statement on Tuesday.

Actelion management has come under fire from activist fund Elliott Advisers which urged the company to put itself up for sale and called for founder and Chief Executive Jean-Paul Clozel as well as Chairman Cawthorn to resign from the board.

Pressure from Elliott, which owns nearly 6% of the $7 billion company, is mounting ahead of Actelion's annual shareholders' meeting on May 5 but the company recently won support from another significant shareholder.

Actelion said it had delivered sustained value creation since its foundation in 1997.

"We believe that the company's corporate governance has been an important component of enabling this outstanding performance," Cawthorn said in the statement.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.